Nina Deka, Senior Research Analyst at ROBO Global, rejoins the show to talk about innovations in health care technology and the companies leading the charge. Labor shortages in skilled personnel and inflationary costs are just two reasons the area is ripe for disruption with automation and digitization. Then there are breakthroughs in treatments and therapies from liquid biopsy to synthetic biology that are elevating the importance of precision medicine. For the video version, visit investors.com/podcast.
Nina Deka, Senior Research Analyst at ROBO Global, rejoins the show to talk about innovations in health care technology and the companies leading the charge. Labor shortages in skilled personnel and inflationary costs are just two reasons the area is ripe for disruption with automation and digitization. Then there are breakthroughs in treatments and therapies from liquid biopsy to synthetic biology that are elevating the importance of precision medicine. For the video version, visit investors.com/podcast.